I'm viewing this relationship as a large pharma and a small biotech.
As impressive as our Phase I trial results have been, at the end of the day it is still only a Phase I.
T/O with just Phase I results would be seen as highly risky from a large pharma.
Large pharma's don't usually become interested in T/O of small biotech's until deep into Phase II trials or may even wait it out to see the final results.
That' why I proposed the above scenario.
However certainly won't complain with a $5 T/O.
Happy either way.
Monday trading halt: option, option plus, or TO?, page-9
-
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.015(6.52%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.5¢ | $15.12K | 67.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 13.49pm 03/12/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
